AUS
NZ
UK
CA
USA
IND
Healt
Neuren Faces Market Challenges Amid European Progress
January 15, 2025 11:46 AM AEDT| By Team Kalkine MediaHighlights,Neuren,Pharmaceuticals (NEU) sees stock decline despite EU progress.,Acadia Pharmaceuticals (ACAD) applies for Rett syndrome treatment approval in Europe.,Significant stock depreciation,noted,over the past year.,Shares of Neuren Pharmaceut...
Biotechnology Partnership Seeks to Expand Rett Syndrome Drug into European Market
January 15, 2025 11:00 AM AEDT| By Team Kalkine MediaBiotechnology Partnership Seeks to Expand Rett Syndrome Drug into European Market
Could Aroa Biosurgery Transform Soft Tissue Regeneration?
January 15, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,Dr. Adam Young's expertise enriches the advanced soft tissue regeneration technology at Aroa Biosurgery (ASX:ARX).,A distinct scientific methodology drives innovations in soft tissue repair.,The technology offers versatility across diverse...
Will US Health Policy Changes Impact Australian Biotech Firms?
January 15, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights:,Robert F. Kennedy Jr. assumes the health secretary role amid policy uncertainties affecting Australian biotech firms in the US.,Companies such as CSL Limited (ASX:CSL), Cochlear Limited (ASX:COH), ResMed Inc. (ASX:RMD), and Fisher & Payke...
Atomo Diagnostics Secures Long-Term Supply Agreement with Newfoundland Diagnostics
January 14, 2025 12:28 PM AEDT| By Team Kalkine MediaHighlights,New Agreement,: Atomo Diagnostics enters a new five-year supply agreement with Newfoundland Diagnostics, worth approximately,AU$5.44 million,.,Exclusive Distribution Rights,: The agreement grants Newfoundland exclusive rights to distribute...
Nanosonics (ASX: NAN) Appoints Gerard Dalbosco to the Board to Strengthen Global Strategy in Healthcare
January 14, 2025 12:26 PM AEDT| By Team Kalkine MediaHighlights,Gerard,Dalbosco,joins,Nanosonics,(NAN) board.,Dalbosco,brings significant,expertise,in finance, M&A, and strategy.,Nanosonics,continues to strengthen its healthcare sector position.,In an exciting development, Nanosonics (ASX:NAN), a leade...
Telix Pharmaceuticals Shares Surge 7% After Outperforming FY24 Guidance
January 14, 2025 11:45 AM AEDT| By Team Kalkine MediaHighlights,Telix Pharmaceuticals shares rise 7% to AU$25.79 following a strong FY24 performance update.,Fourth-quarter unaudited revenue increased 46% year-on-year to US$142 million (AU$218 million), driving full-year revenue up 55% to US$517 million...
Mesoblast Secures $260m to Power Cell Therapy Growth
January 14, 2025 11:38 AM AEDT| By Team Kalkine MediaHighlights,Mesoblast (MSB) completes a $260 million capital raise.,Funds to support,Ryoncil's,US launch and manufacturing expansion.,Shares dipped by 6.4% following the announcement.,Mesoblast Limited (ASX:MSB) has successfully raised $260 million th...
Lumos partners with MedPro to broaden the US distribution of its FebriDx point-of-care respiratory test.
January 14, 2025 11:00 AM AEDT| By Team Kalkine MediaLumos partners with MedPro to broaden the US distribution of its FebriDx point-of-care respiratory test.
Telix Pharmaceuticals Expands Portfolio with $372M ImaginAb Deal
January 13, 2025 01:20 PM AEDT| By Team Kalkine MediaHighlights,Major Acquisition:,Telix Pharmaceuticals is acquiring early-stage drug candidates and a proprietary biologics platform from ImaginAb, Inc. for an initial $73 million, with an additional $299 million tied to future milestones.,Next-Generati...
4D Medical's Radioisotope-Free CT:VQ Technology Set for U.S. Department of Defense Pilot
January 13, 2025 01:16 PM AEDT| By Team Kalkine MediaHighlights:,U.S. DoD Pilot Program:,4D Medical has secured a pilot program with the U.S. Department of Defense to use its CT:VQ lung scanning technology, a major step toward formal FDA approval.,$1 Billion Market Opportunity:,The company aims to repl...
Telix Pharmaceuticals (ASX:TLX) Expands Oncology Pipeline with $372M Asset Acquisition
January 13, 2025 11:13 AM AEDT| By Team Kalkine MediaHighlights:,Telix,Pharmaceuticals Ltd (,ASX:TLX,) secures next-generation cancer drug candidates through a $372 million acquisition agreement with,ImaginAb,, Inc.,The deal includes early-stage assets targeting high-grade neuroendocrine,tumors,, small...
What Do Recent Insider Moves at SomnoMed Reveal?
January 13, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights:,Chairman Gaetano Russo makes a significant stock purchase in SomnoMed.,Insiders collectively own around 7% of the company.,Insider activity over the last year has been focused on acquisitions, with no sales reported,Insider transactions c...
AnteoTech's silicon-dominant anodes are creating a significant impact in the battery industry.
January 12, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights:,AnteoTech advances lithium-ion batteries with silicon anodes, enhancing energy storage and reducing costs.,Collaborations with major companies demonstrate the commercial appeal of this innovative technology.,The focus remains on improving...
Is the Biotech Sector on the Brink of a New Era of Growth?
January 11, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights:,A resurgence in global biotech M&A activity signals renewed interest and growth within the sector, with key acquisitions by companies such as Johnson & Johnson, Eli Lilly, and GlaxoSmithKline.,Dimerix (ASX:DXB) reports significant progres...
Imugene (ASX:IMU) Receives $11.7M R&D Tax Refund to Boost Immunotherapy Developments
January 10, 2025 02:52 PM AEDT| By Team Kalkine MediaHighlights,Imugene (IMU) receives $11.7M tax refund for R&D projects.,The refund is part of Australia's R&D tax incentive scheme.,The refund amount includes both principal and interest.,Imugene (ASX:IMU), an Australian-based immunotherapy company, ha...
ResMed (ASX:RMD): A Strong Contender in the Growing Healthcare Sector
January 10, 2025 01:46 PM AEDT| By Team Kalkine MediaHighlights,ResMed's (RMD) share price has increased by 49% since the start of 2025.,The company has a robust presence in the global healthcare industry, focusing on sleep apnea treatment and software solutions.,Healthcare companies like ResMed are at...
Mesoblast Trading Halt Sparks Market Attention
January 10, 2025 12:31 PM AEDT| By Team Kalkine MediaHighlights,Mesoblast (MSB) enters a trading halt ahead of key announcement.,Trading,expected,to resume on January 14 or sooner if the announcement is made earlier.,Shares experienced a 4% dip during early Friday trading.,Australian biotech company Me...
Lantheus Acquires 12.16% Stake in Radiopharm Theranostics Through $8 Million Placement
January 10, 2025 11:16 AM AEDT| By Team Kalkine MediaHighlights,Lantheus,, a leading radiopharmaceutical company,,acquired,a 12.16% stake in,Radiopharm,Theranostics,(,ASX:RAD,) through an $8 million placement.,The placement price of 6 cents per share,represents,a 150% premium to,Radiopharm's,last closi...
Which healthcare stock experienced a significant drop this week following an earnings downgrade?
January 10, 2025 11:00 AM AEDT| By Team Kalkine MediaWhich healthcare stock experienced a significant drop this week following an earnings downgrade?
Advertise your brand on Kalkine Media